Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rusthoven

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Cancer & Clinical Oncology|November 1, 1985
Clinical significance of natural killer cell cytotoxicity: need for proper data analysis in the design of clinical studiesJ J Rusthoven
Archives of Pathology & Laboratory Medicine|July 1, 1990
Small-cell carcinoma of the vagina. A clinicopathologic studyJ J Rusthoven, D Daya
Southern Medical Journal|November 1, 1978
Hemophilus influenzae f cellulitis with bacteremia, peritonitis, and pleuritis in an adult with nephrotic syndromeJ Rusthoven, S A Kabins
Primary Care|March 1, 1979
Acute lower respiratory diseaseD S Fedson, J Rusthoven
Canadian Medical Association Journal|August 1, 1985
Early-stage Hodgkin's disease: current approaches to treatmentJ J Rusthoven, R MacKenzie
Cellular Immunology|February 1, 1986
Characterization of culture-induced cytotoxicity from human peripheral lymphocyte subpopulationsJ J Rusthoven, D Osoba
Experimental Hematology|May 1, 1980
The use of hydroxyurea to study the proliferative state of T-cell precursors (CFUT) in murine bone marrowJ J Rusthoven, R A Phillips
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1980
Hydroxyurea kills B cell precursors and markedly reduces functional B cell activity in mouse bone marrowJ J Rusthoven, R A Phillips
International Journal of Oncology|May 18, 2011
Ondansetron versus metoclopramide in the prevention of chemotherapy-induced nausea and vomiting - a metaanalysisJ Rusthoven, B Obrien, A Rocchi
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|March 27, 1999
Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site GroupJ Rusthoven, V Bramwell, B Stephenson
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Cancer & Clinical Oncology|November 1, 1985
Clinical significance of natural killer cell cytotoxicity: need for proper data analysis in the design of clinical studiesJ J Rusthoven
Archives of Pathology & Laboratory Medicine|July 1, 1990
Small-cell carcinoma of the vagina. A clinicopathologic studyJ J Rusthoven, D Daya
Southern Medical Journal|November 1, 1978
Hemophilus influenzae f cellulitis with bacteremia, peritonitis, and pleuritis in an adult with nephrotic syndromeJ Rusthoven, S A Kabins
Primary Care|March 1, 1979
Acute lower respiratory diseaseD S Fedson, J Rusthoven
Canadian Medical Association Journal|August 1, 1985
Early-stage Hodgkin's disease: current approaches to treatmentJ J Rusthoven, R MacKenzie
Cellular Immunology|February 1, 1986
Characterization of culture-induced cytotoxicity from human peripheral lymphocyte subpopulationsJ J Rusthoven, D Osoba
Experimental Hematology|May 1, 1980
The use of hydroxyurea to study the proliferative state of T-cell precursors (CFUT) in murine bone marrowJ J Rusthoven, R A Phillips
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1980
Hydroxyurea kills B cell precursors and markedly reduces functional B cell activity in mouse bone marrowJ J Rusthoven, R A Phillips
International Journal of Oncology|May 18, 2011
Ondansetron versus metoclopramide in the prevention of chemotherapy-induced nausea and vomiting - a metaanalysisJ Rusthoven, B Obrien, A Rocchi
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|March 27, 1999
Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site GroupJ Rusthoven, V Bramwell, B Stephenson
Pageof 7